TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?

Understand

Overview

Testosterone replacement therapy (TRT) involves administering exogenous testosterone — as injections, gels, patches, or implants — to men with clinically confirmed hypogonadism, a condition in which the testes fail to produce enough of the hormone. It's a substitution treatment, conceptually similar to giving insulin in type 1 diabetes: it doesn't "add" something beyond normal, it restores hormone concentration to the physiological range in someone whose own production has genuinely failed. That distinction matters, because online and commercial messaging often presents TRT as a universal cure for fatigue, low libido, or "signs of aging" in any man over thirty — which isn't how clinical guidelines define it.

A genuine candidate for TRT is a man whose low testosterone has been confirmed on at least two separate morning blood draws and who has specific clinical symptoms alongside it — reduced libido, erectile dysfunction, loss of muscle mass, infertility, or other symptoms consistent with androgen deficiency. We cover the full diagnostic criteria, including the distinction between primary and secondary hypogonadism, in a separate piece — TRT is a step that follows that diagnosis, never precedes it. Simply feeling unwell, having a low mood, or wanting to "optimize" with a normal testosterone result is not an indication to start therapy, no matter how strongly someone feels it would help them function.

The scientific evidence for what TRT actually improves is stronger for some outcomes than others — and this is one of the most frequently glossed-over facts in popular material about testosterone. Large randomized trials and meta-analyses consistently show a moderate but statistically significant improvement in sexual function (libido, erectile function, sexual satisfaction) and a measurable increase in muscle mass and strength in men with confirmed deficiency. TRT's effect on mood, energy, and cognitive function is considerably weaker and less consistent — some studies note a small mood improvement, especially in younger men with pronounced deficiency, but the largest and best-designed trials (including the Testosterone Trials) found no meaningful improvement in cognitive function, and the effect on energy and vitality is often close to placebo. Anyone expecting TRT to "transform their life" across the board is setting themselves up for disappointment — realistic expectations mean improvement in a few specific, measurable parameters, not a general overhaul of how you feel.

TRT also isn't for everyone with a low result. People with untreated prostate or breast cancer, unexplained elevated PSA, advanced heart failure, untreated severe sleep apnea, or already elevated hematocrit should either not start therapy at all, or only do so after those issues have been investigated and controlled. A separate, often-overlooked group is men planning to father a child in the near future — exogenous testosterone suppresses natural sperm production, so starting TRT without first discussing fertility can be a mistake whose consequences only become apparent when trying to conceive.

It's also worth clearly separating TRT from testosterone and anabolic-androgenic steroid abuse for physique or athletic purposes. TRT aims to restore physiological concentrations (usually within the reference range for healthy young men) under a physician's supervision and with regular blood monitoring. Abuse means doses many times beyond physiological levels, often without a prescription, without a deficiency diagnosis, and without medical oversight — carrying a completely different, considerably worse cardiovascular, hepatic, and hormonal risk profile. Conflating the two — sometimes deliberately in "anti-aging" clinic advertising, sometimes unknowingly in gym conversations — is one of the main sources of confusion about testosterone.

Where it's found

TRT has no single 'origin' in a geographic or natural sense — it's a pharmacological intervention, developed since the early 20th century alongside advances in endocrinology and hormone synthesis chemistry.

History of use

The first (now considered pseudoscientific) attempts to use animal testicular extracts to 'rejuvenate' men date back to the late 19th century (Charles-Édouard Brown-Séquard's experiments, 1889). Testosterone itself wasn't isolated and synthesized until 1935, which made the first short-acting injectable preparations possible. In the following decades, testosterone esters (cypionate, enanthate, among others) were developed to extend duration of action, and transdermal gels became available starting in the 1990s. Today's understanding of TRT as a treatment strictly targeted at men with confirmed hypogonadism — rather than a universal 'anti-aging' therapy — was shaped largely by Endocrine Society clinical guidelines (first version 2006, updated in 2010 and 2018) and by the results of large randomized trials from the past decade, including the Testosterone Trials (2016) and the TRAVERSE cardiovascular safety study (2023).